Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

92 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

NCT01558856

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Clinique Beau Soleil Montpellier, France
  • CHU de Nantes - Hôtel Dieu Nantes, France
  • CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France
  • APHP - Groupe Hospitalier Pitié-Salpetrière Paris, France
View Trial Details
Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00912964

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Chandler, Arizona, United States
View all 151 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

NCT01638000

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site: 37406 Yerevan, Armenia
  • Site: 37404 Yerevan, Armenia
  • Site: 37403 Yerevan, Armenia
  • Site: 37401 Yerevan, Armenia
View all 217 locations
View Trial Details
Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 308 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00662909

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 125 locations
View Trial Details
Completed

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076

NCT01655069

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Site: 1006 Shreveport, Louisiana, United States
  • Site: 3202 Antwerp, Belgium
  • Site: 3209 Antwerp, Belgium
  • Site: 3208 Charleroi, Belgium
View all 39 locations
View Trial Details

Related conditions